Inventor · disambiguated record
Sean M. Johnston
Also filed as: JOHNSTON SEAN · JOHNSTON SEAN M
10 granted patents·17 pending applications·61 citations·filing 2007–2025
88Inventor score
Files withPARATEK PHARM INNC17ALLERGAN PHARMACEUTICALS INT LTD2APNIMED INC DELAWARE2JOHNSTON SEAN2ALEKSHUN MICHAEL N1
Top patents by PatentIndex Score
27 records- 0192US9265740B2Minocycline compounds and methods of use thereofPARATEK PHARMACEUTICALS INC 124418·Filed 2014·Granted Feb 23, 2016·40 cites·23 claims
- 0289US9724358B2Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2016·Granted Aug 8, 2017·6 cites·20 claims
- 0389US2025213595A1Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2024·Application pending·0 cites
- 0487US10124014B2Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2017·Granted Nov 13, 2018·4 cites·2 claims
- 0585US2024226119A9Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2023·Application pending·0 cites
- 0683US9314475B2Oral and injectable formulations of tetracycline compoundsJOHNSTON SEAN·Filed 2009·Granted Apr 19, 2016·3 cites·22 claims
- 0780US8946196B2Methods for synthesizing and purifying aminoalkyl tetracycline compoundsPARATEK PHARM INNC·Filed 2013·Granted Feb 3, 2015·3 cites·28 claims
- 0875US9434680B2Methods for synthesizing and purifying aminoalkyl tetracycline compoundsJOHNSTON SEAN·Filed 2008·Granted Sep 6, 2016·2 cites·44 claims
- 0974US2021121483A1Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2021·Application pending·0 cites
- 1071US12448347B2Polymorphic forms of (R)-oxybutynin hydrochlorideAPNIMED INC DELAWARE·Filed 2021·Granted Oct 21, 2025·0 cites·38 claims
- 1170US9078811B2Methods of increasing oral bioavailability of tetracyclinesALEKSHUN MICHAEL N·Filed 2007·Granted Jul 14, 2015·1 cites·12 claims
- 1269US2020289532A1Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2020·Application pending·0 cites
- 1367US9255068B2Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the sameCOULTER CATHERINE·Filed 2012·Granted Feb 9, 2016·2 cites·72 claims
- 1467US2019142850A1Minocycline compounds and methods of use thereofPARATEK PHARM INNC·Filed 2018·Application pending·0 cites
- 1567US2010113401A1Methods for synthesizing and purifying aminoalkyl tetracycline compoundsPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 1667US2009253660A1Minocycline Compounds and Methods of Use ThereofPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 1758US2020024223A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
- 1857US2023357135A1Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereofPARATEK PHARM INNC·Filed 2021·Application pending·0 cites
- 1956US2024217918A1Solid forms of (r)-oxybutynin d-malateAPNIMED INC DELAWARE·Filed 2022·Application pending·0 cites
- 2055US2019040002A1Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameALLERGAN PHARMACEUTICALS INT LTD·Filed 2018·Application pending·0 cites
- 2154US2017158616A1Methods for synthesizing and purifying aminoalkyl tetracycline compoundsPARATEK PHARM INNC·Filed 2016·Application pending·0 cites
- 2248US2016200671A1Crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the sameWARNER CHILCOTT CO LLC·Filed 2015·Application pending·0 cites
- 2345US2025381203A1Oral and injectable formulations of tetracycline compoundsPARATEK PHARM INNC·Filed 2025·Application pending·0 cites
- 2444US2016030453A1Methods of increasing oral bioavailability of tetracyclinesPARATEK PHARM INNC·Filed 2015·Application pending·0 cites
- 2543US2016279151A1Oral and injectable formulations of tetracycline compoundsPARATEK PHARM INNC·Filed 2016·Application pending·0 cites
- 2642US12297161B2Process for making sarecycline hydrochloridePARATEK PHARM INNC·Filed 2019·Granted May 13, 2025·0 cites·10 claims
- 2740US2013302442A1Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amidePARATEK PHARM INNC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →